Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Oklahoma City, Oklahoma 73104


Purpose:

To determine the therapeutic efficacy of high-dose cyclophosphamide and BCNU with autologous bone marrow transplantation after initial tumor cytoreduction for patients with receptor-negative metastatic breast carcinoma and to determine the optimal timing of CyBCNU-ABMT after initial development of metastatic breast carcinoma


Criteria:

Inclusion Criteria: - breast carcinoma at first clinical evidence of metastatic disease - must have measurable disease by physical exam, x-ray, or scan - Age < or equal to 55 - performance status 0-2 Exclusion Criteria: - can't have had more than one prior chemotherapy regimen - can't have had concurrent hormonal therapy - no brain metastases - no previous pelvic radiation - no history of another malignancy


NCT ID:

NCT00584766


Primary Contact:

Principal Investigator
George Selby, MD
University of Oklahoma


Backup Contact:

N/A


Location Contact:

Oklahoma City, Oklahoma 73104
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 23, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.